ALLMEDTECH.COM
ALLMEDTECH.COM
MEDICAL, SURGICAL, DENTAL,
PHARMACEUTICALS , OBGYN,
VETERINARY & PET SUPPLIES,
DIAGNOSTIC LAB, COSMETICS,
VACCINES , INJECTABLES , IV ,
GENERIC & OTC MEDICATIONS ,
PHARMACY'S AND MED-SPORT
SUPPLIES & EQUIPMENTS
TOLL FREE: 1-800-939-6944
Calvenza-03 EIV/EHV
2 ml (1 Dose)
BOEHRINGER INGELHEIM 139137
2 ml (1 Dose)
BOEHRINGER INGELHEIM 139137
Product Description
Calvenza-03 EIV/EHV
2 ml (1 Dose)
BOEHRINGER INGELHEIM 139137
Specifications Selling Unit of Measure: Each Doses Per Unit: 1 Dose Biological Type: Killed Reconstitution Required: N Color Of Medicine: Opaque Container Type: High Density Plastic Bottle Volume: 2 ml Delivery Type: Injection Presentation: Liquid Diseases Indicated For: Equine herpesvirus Type 1, Equine herpesvirus Type 4, Equine influenza virus A2 North American, Equine influenze virus A2 Eurasian
Product Details For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4 (EVH-4) and by equine influenza type A2 virus.
Benefits: Incorporates the latest emerging North American EIV strain (Ohio/2003), as well as an established North American EIV strain (Kentucky/2/95) Also incorporates a relevant Eurasian EIV strain (Newmarket/2/93) Unique EHV-1 equine respiratory origin isolate Minimal vaccine site reactions Three dose regiment conforms to AAEP recommendations Safe, all killed vaccine
2 ml (1 Dose)
BOEHRINGER INGELHEIM 139137
Specifications Selling Unit of Measure: Each Doses Per Unit: 1 Dose Biological Type: Killed Reconstitution Required: N Color Of Medicine: Opaque Container Type: High Density Plastic Bottle Volume: 2 ml Delivery Type: Injection Presentation: Liquid Diseases Indicated For: Equine herpesvirus Type 1, Equine herpesvirus Type 4, Equine influenza virus A2 North American, Equine influenze virus A2 Eurasian
Product Details For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4 (EVH-4) and by equine influenza type A2 virus.
Benefits: Incorporates the latest emerging North American EIV strain (Ohio/2003), as well as an established North American EIV strain (Kentucky/2/95) Also incorporates a relevant Eurasian EIV strain (Newmarket/2/93) Unique EHV-1 equine respiratory origin isolate Minimal vaccine site reactions Three dose regiment conforms to AAEP recommendations Safe, all killed vaccine
Accessories
 Regular price: $25.00 Sale price: $22.99 |  Regular price: $225.00 Sale price: $199.99 |